Your browser is no longer supported. Please, upgrade your browser.
ABT Abbott Laboratories daily Stock Chart
Abbott Laboratories
IndexS&P 500 P/E48.53 EPS (ttm)1.31 Insider Own0.70% Shs Outstand1.78B Perf Week-2.77%
Market Cap112.68B Forward P/E19.61 EPS next Y3.24 Insider Trans-1.28% Shs Float1.74B Perf Month0.59%
Income2.30B PEG4.10 EPS next Q0.75 Inst Own74.50% Short Float0.76% Perf Quarter2.27%
Sales29.58B P/S3.81 EPS this Y44.60% Inst Trans0.43% Short Ratio2.63 Perf Half Y10.49%
Book/sh17.39 P/B3.65 EPS next Y12.05% ROA1.30% Target Price71.00 Perf Year30.68%
Cash/sh1.84 P/C34.52 EPS next 5Y11.84% ROE3.00% 52W Range48.06 - 65.90 Perf YTD11.14%
Dividend1.12 P/FCF38.80 EPS past 5Y47.40% ROI2.20% 52W High-3.75% Beta1.50
Dividend %1.77% Quick Ratio1.20 Sales past 5Y7.50% Gross Margin57.90% 52W Low31.98% ATR0.86
Employees99000 Current Ratio1.60 Sales Q/Q17.00% Oper. Margin10.10% RSI (14)44.12 Volatility1.10% 1.42%
OptionableYes Debt/Eq0.68 EPS Q/Q162.00% Profit Margin3.10% Rel Volume0.87 Prev Close64.03
ShortableYes LT Debt/Eq0.65 EarningsJul 18 BMO Payout206.60% Avg Volume5.01M Price63.43
Recom1.80 SMA20-1.58% SMA500.48% SMA2006.07% Volume4,407,799 Change-0.94%
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Oct-19-17Reiterated RBC Capital Mkts Outperform $55 → $60
Oct-06-17Resumed JP Morgan Neutral
Sep-28-17Reiterated Barclays Overweight $57 → $60
Aug-17-17Initiated Citigroup Neutral $53
Jun-29-17Resumed Jefferies Buy
Jun-29-17Initiated Guggenheim Buy $58
Jun-21-17Resumed BTIG Research Buy $56
May-16-17Initiated Goldman Neutral $45
Apr-20-17Reiterated Barclays Overweight $50 → $52
Mar-01-17Reiterated RBC Capital Mkts Outperform $46 → $50
Jan-26-17Reiterated RBC Capital Mkts Outperform $48 → $46
Jul-21-16Reiterated Barclays Overweight $48 → $50
Aug-02-18 09:00AM  Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling PR Newswire
08:45AM  What DexCom Just Said About Its Future Motley Fool
08:00AM  Trending: Automakers Breathe Sigh of Relief over U.S.-EU Trade Ceasefire ETF Database
Jul-31-18 06:20AM  Sector Rotation Is Powerful: This Tech Hit Is a Great Trade
Jul-27-18 02:01PM  Wichita hospital selected for medical device clinical trial American City Business Journals
01:00PM  Abbott's FreeStyle® Libre 14 Day Flash Glucose Monitoring System Now Approved in U.S. PR Newswire
10:29AM  Edwards Lifesciences (EW) Q2 Earnings Beat, Revenues Miss Zacks
10:24AM  Omnicell (OMCL) Earnings & Revenues Beat Estimates in Q2 Zacks
02:45AM  Pharma Favorites: 7 Healthy Picks in the Drug Sector Investopedia
Jul-26-18 09:00AM  Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease PR Newswire
Jul-24-18 04:30PM  ViewRay Appoints Scott Drake as President, Chief Executive Officer and a Member of the Board of Directors, Shar Matin as Chief Operating Officer, and D. Keith Grossman as a Member of the Board of Directors PR Newswire
09:31AM  Houston medical device startup hires former Abbott exec as CEO American City Business Journals
Jul-23-18 06:59PM  Cramer Remix: Alphabet has broken this troubling trend after reporting earnings CNBC
04:40PM  Pullback in Abbott Labs Gives Buyers Another Chance
Jul-20-18 10:05AM  Here's Why You Should Add Abbott (ABT) to Your Portfolio Now Zacks
07:30AM  Three Key Takeaways From Healthcare Earnings Season
07:04AM  The Zacks Analyst Blog Highlights: Wells Fargo, IBM, Abbott, Texas Instruments and Praxair Zacks
Jul-19-18 02:01PM  Top Stock Reports for Wells Fargo, IBM & Abbott Zacks
09:24AM  Can Solid Global Prospects Drive Align's (ALGN) Q2 Earnings? Zacks
09:14AM  Benzinga's Daily Biotech Pulse: Novartis Licenses Skin Drug, 2 Stocks To Debut Benzinga
01:38AM  Edited Transcript of ABT earnings conference call or presentation 18-Jul-18 1:00pm GMT Thomson Reuters StreetEvents
Jul-18-18 03:20PM  Abbott (ABT) Q2 Earnings & Revenues Top Estimates, View Up Zacks
02:08PM  Abbott Laboratories Gaps to the Upside in a Classic Breakout
12:38PM  Abbott Laboratories (ABT) Q2 2018 Earnings Conference Call Transcript Motley Fool
12:16PM  Abbott Laboratories Stock Gets a Boost From Q2 Earnings Beat InvestorPlace
11:45AM  Stocks - Morgan Stanley, CSX, United Jump in Pre-market, Google Drops
11:28AM  Abbott Labs Rallies to Record Despite Strong Dollar Bloomberg
10:26AM  Earnings & Economic Data Deluge Zacks
10:14AM  Housing Starts/Permits Disappoint; MS, USB and ABT Beat Zacks
09:21AM  Stocks to Watch: Alphabet, Morgan Stanley, Texas Instruments, United Continental, Boeing, CSX The Wall Street Journal
09:08AM  Abbott (ABT) Beats on Earnings and Revenues in Q2 Zacks
08:33AM  3 Big Stock Charts for Wednesday: United Technologies, Abbott Laboratories and Leggett & Platt InvestorPlace
08:16AM  Abbott Shares Rise on Second-Quarter Beat, Increased Guidance
08:00AM  Abbott Labs shares lift 2.5% after Q2 profit, revenue beats MarketWatch
07:55AM  Abbott: 2Q Earnings Snapshot Associated Press
07:45AM  Abbott Reports Second-Quarter 2018 Results PR Newswire
Jul-17-18 07:37PM  Day Ahead: Top 3 Things to Watch
06:13PM  Powell testimony, Morgan Stanley earnings What you need to know in markets on Wednesday Yahoo Finance
04:21PM  Abbott's Capital Flexibility in Focus Ahead of Earnings Release
03:07PM  Earnings Preview For Abbott Laboratories Benzinga
01:01PM  The traders' positions on Twilio and Abbott Labs CNBC Videos
Jul-13-18 07:30AM  [$$] Look Who's Buying Verizon and JPMorgan
Jul-12-18 09:58AM  Can Established Pharmaceuticals Up Abbott (ABT) Q2 Earnings? Zacks
09:37AM  Can Medical Devices Strength Drive Abbott (ABT) Q2 Earnings? Zacks
09:00AM  Abbott Receives FDA Approval for Next-Generation MitraClip® Device to Treat People with Leaky Heart Valves PR Newswire
Jul-11-18 11:41AM  Can Abbott (ABT) Rise on Robust Overall Growth in Q2 Earnings? Zacks
Jul-10-18 07:15AM  EX-Dividend Schedule: Abbott Laboratories Announced its 378th Consecutive Dividend; Will Trade Ex-Dividend on July 12, 2018 ACCESSWIRE
Jul-09-18 05:25PM  There may be politics but there is no debate: Breastfeeding is the best health option CNBC
03:42PM  Trump Today: President blasts NATO allies, Pfizer and China ahead of Supreme Court decision MarketWatch
02:39PM  Health Care Sector Outlook: Checking In Ahead Of Q2 Earnings Reports Benzinga
Jul-06-18 12:59PM  Top Stocks Set to Disrupt the Diabetes Market Motley Fool
Jul-05-18 10:36AM  Here's Why AbbVie Stock is Good for Your Portfolio's Health Zacks
07:20AM  Free Technical Research on Abbott Laboratories and Three More Medical Equipment Equities ACCESSWIRE
Jun-29-18 10:48AM  Medical Device ETFs Still Look Healthy ETF Trends
09:57AM  Interested In Pharmaceutical Stocks? Try Novartis (ADR) Investopedia
Jun-27-18 08:24AM  The Zacks Analyst Blog Highlights: Facebook, Amgen, Abbott, Coca-Cola and 3M Zacks
07:42AM  Stocks making the biggest moves in the premarket: CAG, PF, GIS, TEVA, WWE & more CNBC
Jun-26-18 11:12AM  Top Stock Reports for Facebook, Amgen & Abbott Zacks
07:00AM  Abbott Announces Freedom 2 Save Program for Employees to Address Student Debt PR Newswire
Jun-25-18 09:00AM  New Late-Breaking Data at ADA Underscore Significant Benefits of Abbott's FreeStyle Libre System for People Living with Diabetes PR Newswire
Jun-22-18 10:30AM  What You Must Know About Abbott Laboratoriess (NYSE:ABT) Financial Strength Simply Wall St.
Jun-21-18 08:28AM  Tap Cardiovascular Devices Market Boom With These 3 Stocks Zacks
Jun-20-18 09:00AM  Abbott Hosts Conference Call for Second-Quarter Earnings PR Newswire
Jun-18-18 07:28AM  Zacks Industry Outlook Highlights: Boston Scientific, Stryker, Medtronic, Abbott and Varian Medical Zacks
Jun-14-18 07:33PM  Should You Be Concerned With Abbott Laboratoriess (NYSE:ABT) -73.52% Earnings Drop? Simply Wall St.
08:28AM  Allergan appoints former Abbott executive to its board Reuters
07:30AM  Report: Developing Opportunities within Abbott Laboratories, Markel, Microsoft, Gazit-Globe, National General, and ANGI Homeservices Future Expectations, Projections Moving into 2018 GlobeNewswire
Jun-13-18 07:32PM  Cramer continues review of $100 billion club with 2018's ... CNBC Videos
07:24PM  DexCom Stock History Motley Fool
07:08PM  Cramer introduces the market's newest high-quality stock group: The $100 billion club CNBC
11:58AM  10 Dividend Aristocrats You Never Have to Worry About InvestorPlace
Jun-08-18 10:15AM  Abbott Declares 378th Consecutive Quarterly Dividend PR Newswire
09:14AM  Bio-Rad Banks on Solid Global Scenario, Competition Rife Zacks
Jun-06-18 06:09PM  The brain stimulator communicator: Tears of joy are just a happy byproduct in managers line of work American City Business Journals
Jun-05-18 01:22PM  For investors looking for a summer fling, one sector could fit the bill CNBC
Jun-01-18 03:24PM  Abbott Launches Afinion 2 Analyzer Rapid Test in the U.S. Zacks
May-31-18 08:00AM  Abbott Introduces the Afinion 2 Analyzer Rapid Test System for Diabetes Management PR Newswire
May-30-18 10:35AM  Jim Cramer's List of 88 Stocks to Watch With Interest Rates Falling Again
May-29-18 02:52PM  Medical Device Stocks Could Be Gearing Up to Be Market Leaders
10:24AM  The 7 Best Long-Term Stocks for Risk-Off Investors InvestorPlace
07:28AM  The Zacks Analyst Blog Highlights: Duke, Charter Communications, Abbott, UnitedHealth and Brown-Forman Zacks
May-28-18 10:35AM  2 Giant Medical Device Companies Transforming Diabetes Motley Fool
08:40AM  Abbott Presents Positive Data for AMPLATZER Amulet Device Zacks
May-25-18 06:32PM  How to Invest in Diabetes Stocks Motley Fool
12:43PM  Top Stock Reports for Duke Energy, Charter Communications & Abbott Zacks
12:40PM  Five Top MedTech Stocks in Diabetes Motley Fool
12:13PM  A Focus on Eye Care Is Setting Up Johnson & Johnson Stock for the Future InvestorPlace
10:15AM  Abbott Presents Positive Study Results for Tendyne Device Zacks
May-24-18 09:26AM  Abbott Gets FDA Nod for XIENCE Sierra, To Boost Vascular Wing Zacks
07:05AM  Abbott Labs and Three Additional Medical Equipment Stocks on Our Research Desks Radar ACCESSWIRE
May-23-18 09:00AM  Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease PR Newswire
06:00AM  Abbott's Investigational Tendyne Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study PR Newswire
May-22-18 06:20AM  Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions PR Newswire
May-21-18 06:00AM  Shocking the Spine Offers an Alternative to Opioids Bloomberg
May-18-18 09:20AM  Why Is Abbott (ABT) Up 2% Since Its Last Earnings Report? Zacks
May-14-18 06:59PM  Will Abbott Laboratories (NYSE:ABT) Continue To Underperform Its Industry? Simply Wall St.
May-11-18 01:33PM  [$$] Heart Device Procedure Is No Better Than Drug Therapy for Irregular Heartbeat: Study The Wall Street Journal
May-07-18 05:31PM  Is It Time To Buy Abbott Laboratories (NYSE:ABT)? Simply Wall St.
May-04-18 04:01PM  Despite Youth On Farm, Abbott Ventures Chief Avoids Spreading Manure Forbes
May-03-18 09:00AM  Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter PR Newswire
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; and anti-infective clarithromycin, as well as provides influenza vaccine and products that regulate physiological rhythm of the colon. Its Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; benchtop systems and rapid tests in the areas of infectious diseases; molecular point-of-care test systems for influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bracken Sharon JSenior Vice PresidentJul 30Sale65.1661540,07340,761Jul 31 05:01 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Option Exercise26.0264,9001,688,374363,200Jul 26 05:05 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Sale65.0064,9004,218,500298,300Jul 26 05:05 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 24Sale63.5080350,99178,417Jul 24 05:02 PM
Blaser Brian JExecutive Vice PresidentJul 24Sale63.9615,100965,789136,818Jul 26 05:09 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 23Sale63.2024715,61079,220Jul 24 05:02 PM
Bracken Sharon JSenior Vice PresidentJul 23Sale63.2025916,36941,376Jul 24 05:01 PM
Funck Robert ESenior Vice PresidentJun 05Option Exercise26.0212,800332,992117,293Jun 07 05:08 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMay 18Sale61.501,00061,50094,581May 21 05:16 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMay 17Sale61.052,000122,09295,581May 21 05:16 PM
Bracken Sharon JSenior Vice PresidentMay 04Sale58.562,150125,90942,140May 08 05:00 PM
Contreras JaimeSenior Vice PresidentApr 23Sale59.3684950,3972,595Apr 25 05:12 PM
BIRD ROGERSenior Vice PresidentMar 09Sale62.758,262518,45058,174Mar 13 05:03 PM
Watkin JaredSenior Vice PresidentMar 07Sale61.193,000183,57965,515Mar 09 05:01 PM
Bracken Sharon JSenior Vice PresidentMar 05Sale60.272,100126,55944,290Mar 07 05:11 PM
Fussell Stephen RExecutive Vice PresidentMar 01Sale60.1311,106667,804161,052Mar 02 05:17 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 01Sale58.9790553,36997,581Mar 02 05:15 PM
Watkin JaredSenior Vice PresidentMar 01Sale58.8799658,63568,515Mar 02 05:15 PM
MANNING JOSEPH JSenior Vice PresidentMar 01Sale58.981,43084,34438,466Mar 02 05:14 PM
Contreras JaimeSenior Vice PresidentMar 01Sale59.746,284375,38150,436Mar 02 05:13 PM
Funck Robert ESenior Vice PresidentMar 01Sale58.991,22071,970104,493Mar 02 05:11 PM
BIRD ROGERSenior Vice PresidentMar 01Sale58.801,64596,72866,436Mar 02 05:13 PM
Bracken Sharon JSenior Vice PresidentMar 01Sale58.931,05362,05646,390Mar 02 05:09 PM
STARKS DANIEL JDirectorFeb 27Buy60.7729,5541,795,9017,012,839Feb 28 06:35 PM
STARKS DANIEL JDirectorFeb 27Buy60.8740024,3487,013,239Feb 28 06:36 PM
STARKS DANIEL JDirectorFeb 27Buy60.6740,0372,429,2376,983,285Feb 28 06:34 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Option Exercise38.40104,6424,018,253289,526Feb 21 07:23 PM
Watkin JaredSenior Vice PresidentFeb 20Sale59.2929717,60973,377Feb 21 06:21 PM
PEDERSON MICHAEL JSenior Vice PresidentFeb 20Sale59.2945927,21382,069Feb 21 06:18 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.845,532331,048184,884Feb 21 07:24 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.6156,4013,361,948233,125Feb 21 07:23 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.7342,7092,550,813190,416Feb 21 07:23 PM
Blaser Brian JExecutive Vice PresidentJan 31Option Exercise22.3927,733620,995156,587Feb 01 05:50 PM
Blaser Brian JExecutive Vice PresidentJan 31Sale62.2627,7331,726,634128,854Feb 01 05:50 PM
Fussell Stephen RExecutive Vice PresidentJan 31Sale62.681,00062,680561,518Feb 01 05:48 PM
Ford Robert BExecutive Vice PresidentJan 30Option Exercise31.0583,4672,591,776135,633Feb 01 05:47 PM
Fussell Stephen RExecutive Vice PresidentJan 30Option Exercise37.32388,98314,516,345571,121Feb 01 05:48 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.83161,37110,139,045182,338Feb 01 05:48 PM
Ford Robert BExecutive Vice PresidentJan 30Sale62.9842,6652,687,13492,968Feb 01 05:47 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.7729,0501,823,535153,288Feb 01 05:49 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.8413,313836,607139,975Feb 01 05:49 PM
Ford Robert BExecutive Vice PresidentJan 30Sale63.0340,8022,571,62452,166Feb 01 05:47 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.75226,41214,207,000343,709Feb 01 05:48 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentDec 14Option Exercise47.0028,3191,330,993102,117Dec 14 06:01 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentDec 14Sale54.9228,3191,555,26073,798Dec 14 06:01 PM
WHITE MILES DChairman and CEODec 06Option Exercise26.70530,00014,149,5693,677,913Dec 08 05:26 PM
WHITE MILES DChairman and CEODec 06Sale54.9410,644584,8273,148,022Dec 08 05:29 PM
WHITE MILES DChairman and CEODec 06Sale54.7049,2032,691,2243,230,087Dec 08 05:27 PM
WHITE MILES DChairman and CEODec 06Sale54.8371,5303,921,6403,158,557Dec 08 05:28 PM
WHITE MILES DChairman and CEODec 06Sale54.41276,88615,064,6933,401,027Dec 08 05:26 PM
WHITE MILES DChairman and CEODec 06Sale54.50121,7376,635,2153,279,290Dec 08 05:26 PM
Bracken Sharon JSenior Vice PresidentNov 30Sale56.122,188122,79525,018Dec 01 05:08 PM
Wellisch Alejandro DSenior Vice PresidentNov 22Sale55.862,153120,2708,803Nov 22 05:15 PM
Blaser Brian JExecutive Vice PresidentNov 17Option Exercise24.239,566231,768152,720Nov 20 05:16 PM
Blaser Brian JExecutive Vice PresidentNov 17Sale55.5523,8661,325,720128,854Nov 20 05:16 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentNov 14Option Exercise38.4071,1572,732,429144,955Nov 16 05:06 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentNov 14Sale55.0071,1573,913,63573,798Nov 16 05:06 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentOct 23Option Exercise43.5296,6034,204,384170,401Oct 25 05:03 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentOct 23Sale56.2196,6035,430,05573,798Oct 25 05:03 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Option Exercise44.3162,4602,767,646141,745Sep 28 05:13 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Sale52.9562,4603,307,25779,285Sep 28 05:13 PM
Contreras JaimeSenior Vice PresidentSep 22Option Exercise25.2952,7001,333,03798,039Sep 26 05:47 PM
Contreras JaimeSenior Vice PresidentSep 22Sale51.9752,7002,738,60345,339Sep 26 05:47 PM
Fussell Stephen RExecutive Vice PresidentAug 16Option Exercise25.56196,5505,023,939378,688Aug 18 05:10 PM
Fussell Stephen RExecutive Vice PresidentAug 16Sale49.50196,5509,729,225182,138Aug 18 05:10 PM